Recurrent PIK3CA mutations in rosette-forming glioneuronal tumor (original) (raw)

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Bettegowda C, Agrawal N, Jiao Y et al (2011) Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science 333:1453–1455
    Article PubMed CAS Google Scholar
  2. Broderick DK, Di C, Parrett TJ, Samuels YR, Cummins JM, McLendon RE, Fults DW, Velculescu VE, Bigner DD, Yan H (2004) Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas. Cancer Res 64:5048–5050
    Article PubMed CAS Google Scholar
  3. Broniscer A, Baker SJ, West AN et al (2007) Clinical and molecular characteristics of malignant transformation of low-grade glioma in children. J Clin Oncol 25:682–689
    Article PubMed CAS Google Scholar
  4. Gessi M, Waha A, Setty P, Pietsch T (2011) Analysis of KIAA1549–BRAF fusion status in a case of rosette-forming glioneuronal tumor of the fourth ventricle (RGNT). Neuropathology. doi:10.1111/j.1440-1789.2011.01220.x
  5. Hainfellner JA, Scheithauer BW, Giangaspero F, Rosenblum MK (2007) Rosette-forming glioneuronal tumour of the fourth ventricle. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system, 4th edn. International Agency for Research on Cancer, Lyon, pp 115–116
    Google Scholar
  6. Hartmann C, Bartels G, Gehlhaar C, Holtkamp N, von Deimling A (2005) PIK3CA mutations in glioblastoma multiforme. Acta Neuropathol 109:639–642
    Article PubMed CAS Google Scholar
  7. Hartmann C, Devermann L, Gehlhaar C, Holtkamp N, von Deimling A (2006) PIK3CA mutations in oligodendroglial tumours. Neuropathol Appl Neurobiol 32:209–212
    Article PubMed CAS Google Scholar
  8. Jacques TS, Eldridge C, Patel A, Saleem NM, Powell M, Kitchen ND, Thom M, Revesz T (2006) Mixed glioneuronal tumour of the fourth ventricle with prominent rosette formation. Neuropathol Appl Neurobiol 32:217–220
    Article PubMed CAS Google Scholar
  9. Koul D (2008) PTEN signaling pathways in glioblastoma. Cancer Biol Ther 7:1321–1325
    Article PubMed CAS Google Scholar
  10. Rodriguez EF, Scheithauer BW, Giannini C, Rynearson A, Cen L, Hoesley B, Gilmer-Flynn H, Sarkaria JN, Jenkins S, Long J, Rodriguez FJ (2011) PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma. Acta Neuropathol 121:407–420
    Article PubMed CAS Google Scholar
  11. Samuels Y, Wang Z, Bardelli A et al (2004) High frequency of mutations of the PIK3CA gene in human cancers. Science 304:554
    Article PubMed CAS Google Scholar
  12. Sasaki H, Zlatescu MC, Betensky RA, Ino Y, Cairncross JG, Louis DN (2001) PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis. Am J Pathol 159:359–367
    Article PubMed CAS Google Scholar
  13. Schindler G, Capper D, Meyer J et al (2011) Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 121:397–405
    Article PubMed CAS Google Scholar
  14. Thomas RK, Baker AC, DeBiasi RM et al (2007) High-throughput oncogene mutation profiling in human cancer. Nat Genet 39:347–351
    Article PubMed CAS Google Scholar
  15. Wick W, Weller M, Weiler M, Batchelor T, Yung AW, Platten M (2011) Pathway inhibition: emerging molecular targets for treating glioblastoma. Neuro Oncol 13:566–579
    Article PubMed CAS Google Scholar

Download references

Acknowledgments

We would like to thank Bedia Barkoh from MDACC’s Molecular Diagnostic laboratory for technical assistance with Sequenom™ testing and Vidya Mehta from Texas Children’s Hospital for FISH testing.

Author information

Authors and Affiliations

  1. Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Benjamin Ellezam & Kenneth D. Aldape
  2. Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Brett J. Theeler & Mark R. Gilbert
  3. Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Rajyalakshmi Luthra
  4. Department of Pathology, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX, USA
    Benjamin Ellezam & Adekunle M. Adesina

Authors

  1. Benjamin Ellezam
    You can also search for this author inPubMed Google Scholar
  2. Brett J. Theeler
    You can also search for this author inPubMed Google Scholar
  3. Rajyalakshmi Luthra
    You can also search for this author inPubMed Google Scholar
  4. Adekunle M. Adesina
    You can also search for this author inPubMed Google Scholar
  5. Kenneth D. Aldape
    You can also search for this author inPubMed Google Scholar
  6. Mark R. Gilbert
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toBenjamin Ellezam.

Additional information

B. Ellezam and B. J. Theeler contributed equally to the work.

Rights and permissions

About this article

Cite this article

Ellezam, B., Theeler, B.J., Luthra, R. et al. Recurrent PIK3CA mutations in rosette-forming glioneuronal tumor.Acta Neuropathol 123, 285–287 (2012). https://doi.org/10.1007/s00401-011-0886-z

Download citation

Keywords